3
Oct 1 (Reuters) – Wave Life Sciences Ltd.: * WAVE LIFE SCIENCES ANNOUNCES FDA FEEDBACK SUPPORTS REGISTRATIONAL PATHWAY FOR WVE-006 (RNA EDITING) IN AATD * WAVE LIFE SCIENCES – PLANS TWO-YEAR
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
